2025 annual financial data
Dogwood Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -27,968,445 USD and net income was -34,257,370 USD.
Operating cash flow was -15,618,651 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -27,968,445 USD
- Net income
- -34,257,370 USD
- Operating cash flow
- -15,618,651 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Dogwood Therapeutics financial years